Calton & Associates’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Calton & Associates's MDT Position: Q2 2023 in Review
Calton & Associates sold out of Medtronic (MDT) in Q2 2023, closing a stake of 11,867 shares — an estimated $957K sold.
Calton & Associates first reported a position in MDT in Q4 2017 and held it in 18 quarters. The position peaked at $1.8M in Q4 2017. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.
- Calton & Associates reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
- Calton & Associates sold 11,867 Medtronic shares in Q2 2023, an estimated $957K.
- Calton & Associates first reported a position in Medtronic in Q4 2017 and held it in 18 quarters.
- Calton & Associates's Medtronic position peaked at $1.8M in Q4 2017.
- 2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.
Based on Calton & Associates's 13F filing for Q2 2023, filed 24 Jul 2023.